Wuhan Thalys Med Tech Co Ltd (603716) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Wuhan Thalys Med Tech Co Ltd (603716) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥54.57 Million ≈ $7.99 Million USD) by net assets (CN¥1.05 Billion ≈ $154.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Wuhan Thalys Med Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Wuhan Thalys Med Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Wuhan Thalys Med Tech Co Ltd (603716) financial obligations for a breakdown of total debt and financial obligations.

Wuhan Thalys Med Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Thalys Med Tech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen AV-Display Co. Ltd. SHE:300939	0.017x
Thornburg Income Builder Opportunities Trust Common Stock NASDAQ:TBLD	N/A
Qualitau Ltd TA:QLTU	-0.058x
YG Entertainment Inc KQ:122870	0.041x
Changzhou Langbo Seal Polytron Technologies Co Ltd Class A SHG:603655	0.016x
JSE Limited JSE:JSE	0.140x
Sichuan Zhongguang Lightning Protection Technologies Co Ltd SHE:300414	0.005x
Cashway Technology Co Ltd SHG:603106	-0.015x

Annual Cash Flow Conversion Efficiency for Wuhan Thalys Med Tech Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Wuhan Thalys Med Tech Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Wuhan Thalys Med Tech Co Ltd (603716) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥962.04 Million ≈ $140.78 Million	CN¥99.60 Million ≈ $14.57 Million	0.104x	+8.12%
2023-12-31	CN¥1.31 Billion ≈ $192.38 Million	CN¥125.89 Million ≈ $18.42 Million	0.096x	+409.71%
2022-12-31	CN¥1.50 Billion ≈ $219.05 Million	CN¥28.12 Million ≈ $4.12 Million	0.019x	+124.52%
2021-12-31	CN¥1.74 Billion ≈ $255.04 Million	CN¥-133.52 Million ≈ $-19.54 Million	-0.077x	-1488.68%
2020-12-31	CN¥1.80 Billion ≈ $263.77 Million	CN¥9.94 Million ≈ $1.46 Million	0.006x	-90.48%
2019-12-31	CN¥1.62 Billion ≈ $237.21 Million	CN¥93.92 Million ≈ $13.74 Million	0.058x	+247.56%
2018-12-31	CN¥1.63 Billion ≈ $237.88 Million	CN¥-63.83 Million ≈ $-9.34 Million	-0.039x	+37.69%
2017-12-31	CN¥1.00 Billion ≈ $146.88 Million	CN¥-63.25 Million ≈ $-9.26 Million	-0.063x	-218.21%
2016-12-31	CN¥859.29 Million ≈ $125.74 Million	CN¥-17.02 Million ≈ $-2.49 Million	-0.020x	-120.20%
2015-12-31	CN¥470.30 Million ≈ $68.82 Million	CN¥46.11 Million ≈ $6.75 Million	0.098x	+32.39%
2014-12-31	CN¥405.99 Million ≈ $59.41 Million	CN¥30.07 Million ≈ $4.40 Million	0.074x	-21.25%
2013-12-31	CN¥345.97 Million ≈ $50.63 Million	CN¥32.54 Million ≈ $4.76 Million	0.094x	+933.02%
2012-12-31	CN¥296.50 Million ≈ $43.39 Million	CN¥2.70 Million ≈ $394.98K	0.009x	+109.55%
2011-12-31	CN¥253.90 Million ≈ $37.15 Million	CN¥-24.22 Million ≈ $-3.54 Million	-0.095x	--

About Wuhan Thalys Med Tech Co Ltd

SHG:603716 China Diagnostics & Research

Market Cap

$678.46 Million

CN¥4.64 Billion CNY

Market Cap Rank

#11004 Global

#3262 in China

Share Price

CN¥21.26

Change (1 day)

+0.95%

52-Week Range

CN¥10.86 - CN¥36.40

All Time High

CN¥45.48